High-intensity focused ultrasound treatment in 341 cases of advanced cancer patient outcomes.docVIP

 PAGE \* MERGEFORMAT 16 High-intensity focused ultrasound treatment in 341 cases of advanced cancer patient outcomes Of: Zhouhong Ping, Ping Zhihong, Yang Yuzhi, fees wave [Abstract] Objective To observe and analyze the high-intensity focused ultrasound in patients with advanced cancer patients. Methods FEP-BY02-type high-intensity focused ultrasound in the treatment of 347 cases of advanced cancer patients. According to the patients physical condition, tumor characteristics and treatment compliance, etc. to give 0.2 ~ 1.0 kW of transmit power, after the treatment efficacy and safety. Results 341 cases is expected to complete treatment programs, combined with chemotherapy in 69 patients, combined with radiotherapy in 57 cases. Recently the total effective rate 79.1%, clinical benefit rate was 86.2% . 23 cases of bleeding, gastrointestinal complications such as paralysis and skin burns. Conclusion The preoperative assessment of patients with tumor characteristics, adjust the treatment parameters and combined with other treatments help to improve the curative effect and reduce complications. [Key Words] high intensity focused ultrasound; in advanced cancer; treatment parameters; clinical value Abstract: Objective To observe and analyze the clinical value of the treatment with high-intensity focused ultrasound (HIFU) in patients with advanced malignant tumors. Methods 347 patients with advanced malignant tumors were designated as the candidates and were treated with FEP-BY02. The emission power of 0.2 ~ 1kW was applied to individuals according to physical conditions, tumor characteristics and compliance. Then recent curative effect and security were observed and analyzed. Results Among 347 patients with advanced malignant tumors, 341 cases were treated by appointment, 69 and 57 cases underwent combined regimen with chemotherapy and radiotherapy, respectively. The recent overall response rate was 79.1%. The clinical benefit response was 86.2%. Whereas 2